{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-28T15:37:52.815058+00:00","company":{"ticker":"DCGO","cik":1822359,"company_name":"DocGo Inc."},"pagination":{"limit":100,"returned":49,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Citibank, N.A.","detail":"credit_facility","count":1,"first_seen":"2024-01-31T23:59:59+00:00","last_seen":"2024-01-31T23:59:59+00:00","evidence_fact_ids":[78182]},{"display_name":"Citibank, N.A., as administrative agent, and the lenders party thereto","detail":"credit_facility","count":1,"first_seen":"2022-11-02T23:59:59+00:00","last_seen":"2022-11-02T23:59:59+00:00","evidence_fact_ids":[200889]}],"lender":[{"display_name":"Citibank, N.A.","detail":"revolving_credit","count":1,"first_seen":"2022-11-02T23:59:59+00:00","last_seen":"2022-11-02T23:59:59+00:00","evidence_fact_ids":[200890]}]},"facts":[{"fact_type":"shareholder_vote","fact_key":"cf7a3150379137716fb1fbba732e6438e2951aa6","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-06-18T21:06:04+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-16","outcome":"passed","proposal_text":"Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"—","subject":null,"votes_abstain":"500,703","votes_against":"3,874,903","votes_for":"67,639,242","votes_withheld":null}]},"claim":"DocGo Inc. shareholders approved Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-16 meeting.","evidence_excerpt":"6.    Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026: Votes For Votes Against Abstentions Broker Non-Votes 67,639,242 3,874,903 500,703 — Pursuant to the foregoing vote, the stockholders ratified the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-044414","anchor_url":"https://secwatch.observer/filing/0001628280-26-044414#claim-cf7a3150379137716fb1fbba732e6438e2951aa6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000162828026044414/0001628280-26-044414-index.htm"},{"fact_type":"shareholder_vote","fact_key":"225fbce4bb1490b74f6fd75ed5a49fdbadbba69b","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-06-18T21:06:04+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-16","outcome":"failed","proposal_text":"To approve an amendment to the Charter to limit the liability of certain officers as permitted by Delaware law (the “Officer Exculpation Amendment”)","proposal_type":"charter_amendment","results":[{"broker_non_votes":"21,849,313","subject":null,"votes_abstain":"747,070","votes_against":"5,990,544","votes_for":"43,427,921","votes_withheld":null}]},"claim":"DocGo Inc. shareholders rejected To approve an amendment to the Charter to limit the liability of certain officers as permitted by Delaware law (the “Officer Exculpation Amendment”) at the 2026-06-16 meeting.","evidence_excerpt":"5.    To approve an amendment to the Charter to limit the liability of certain officers as permitted by Delaware law (the “Officer Exculpation Amendment”): Votes For Votes Against Abstentions Broker Non-Votes 43,427,921 5,990,544 747,070 21,849,313 Pursuant to the foregoing vote, stockholders representing the requisite number of shares did not approve the Officer Exculpation Amendment necessary to amend the Charter.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-044414","anchor_url":"https://secwatch.observer/filing/0001628280-26-044414#claim-225fbce4bb1490b74f6fd75ed5a49fdbadbba69b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000162828026044414/0001628280-26-044414-index.htm"},{"fact_type":"shareholder_vote","fact_key":"f42cedcc58320b8697f7a5806e3b3c0050f06985","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-06-18T21:06:04+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-16","outcome":"failed","proposal_text":"To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Charter”) regarding the waiver of corporate opportunities (the “Corporate Opportunity Amendment”)","proposal_type":"charter_amendment","results":[{"broker_non_votes":"21,849,313","subject":null,"votes_abstain":"628,084","votes_against":"8,726,933","votes_for":"40,810,518","votes_withheld":null}]},"claim":"DocGo Inc. shareholders rejected To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Charter”) regarding the waiver of corporate opportunities (the “Corporate Opportunity Amendment”) at the 2026-06-16 meeting.","evidence_excerpt":"4.    To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Charter”) regarding the waiver of corporate opportunities (the “Corporate Opportunity Amendment”): Votes For Votes Against Abstentions Broker Non-Votes 40,810,518 8,726,933 628,084 21,849,313 Pursuant to the foregoing vote, stockholders representing the requisite number of shares did not approve the Corporate Opportunity Amendment necessary to amend the Charter.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-044414","anchor_url":"https://secwatch.observer/filing/0001628280-26-044414#claim-f42cedcc58320b8697f7a5806e3b3c0050f06985","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000162828026044414/0001628280-26-044414-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3b79e173aae40078aec9ec48c1ecb5be14d529db","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-06-18T21:06:04+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-16","outcome":"passed","proposal_text":"To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 to be determined in the sole discretion of the Company’s Board of Directors.","proposal_type":"reverse_split","results":[{"broker_non_votes":"—","subject":null,"votes_abstain":"199,608","votes_against":"5,673,628","votes_for":"66,141,612","votes_withheld":null}]},"claim":"DocGo Inc. shareholders approved To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 to be determined in the sole discretion of the Company’s Board of Directors. at the 2026-06-16 meeting.","evidence_excerpt":"3.    To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 to be determined in the sole discretion of the Company’s Board of Directors. Votes For Votes Against Abstentions Broker Non-Votes 66,141,612 5,673,628 199,608 — Pursuant to the foregoing vote, the stockholders approved the proposed reverse stock split.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-044414","anchor_url":"https://secwatch.observer/filing/0001628280-26-044414#claim-3b79e173aae40078aec9ec48c1ecb5be14d529db","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000162828026044414/0001628280-26-044414-index.htm"},{"fact_type":"shareholder_vote","fact_key":"363e9b82b2c29d4d8dfcebddb056ace1110487e4","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-06-18T21:06:04+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-16","outcome":"passed","proposal_text":"To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers","proposal_type":"say_on_pay","results":[{"broker_non_votes":"21,849,313","subject":null,"votes_abstain":"183,325","votes_against":"10,213,238","votes_for":"39,768,972","votes_withheld":null}]},"claim":"DocGo Inc. shareholders approved To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers at the 2026-06-16 meeting.","evidence_excerpt":"2.    To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers: Votes For Votes Against Abstentions Broker Non-Votes 39,768,972 10,213,238 183,325 21,849,313 Pursuant to the foregoing vote, the stockholders approved on a non-binding, advisory basis the compensation of the Company’s named executive officers.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-044414","anchor_url":"https://secwatch.observer/filing/0001628280-26-044414#claim-363e9b82b2c29d4d8dfcebddb056ace1110487e4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000162828026044414/0001628280-26-044414-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d8237fddb6e4589210d6ce0f83b21d0e31fd3306","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-06-18T21:06:04+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-16","outcome":"passed","proposal_text":"Election of the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified","proposal_type":"director_election","results":[{"broker_non_votes":"21,849,313","subject":"Vina Leite","votes_abstain":null,"votes_against":null,"votes_for":"31,241,093","votes_withheld":"18,924,442"},{"broker_non_votes":"21,849,313","subject":"James M. Travers","votes_abstain":null,"votes_against":null,"votes_for":"25,062,607","votes_withheld":"25,102,928"}]},"claim":"DocGo Inc. shareholders approved Election of the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified at the 2026-06-16 meeting.","evidence_excerpt":"1.    Election of the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Director Nominee Votes For Votes Withheld Broker Non-Votes Vina Leite 31,241,093 18,924,442 21,849,313 James M. Travers 25,062,607 25,102,928 21,849,313 Pursuant to the foregoing votes, the two nominees listed above were elected to serve on the Company’s Board of Directors.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-044414","anchor_url":"https://secwatch.observer/filing/0001628280-26-044414#claim-d8237fddb6e4589210d6ce0f83b21d0e31fd3306","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000162828026044414/0001628280-26-044414-index.htm"},{"fact_type":"earnings_release","fact_key":"5943af32a8e9f932460a31bdd10cafa6e06ecfa7","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-05-11T20:09:20+00:00","payload":{"eps_text":null,"guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"($16.7) million","period_text":"the first quarter ended March 31, 2026","report_date":"2026-05-11","result_type":"reported_results","revenue_text":"$75.6 million"},"claim":"DocGo Inc. reported the first quarter ended March 31, 2026 results: revenue $75.6 million, net income ($16.7) million. Guidance raised.","evidence_excerpt":"announced financial and operating results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights • Total revenue for the first quarter of 2026 was $75.6 million, compared to $96.0 million in the first quarter of 2025. This decline was entirely due to the wind-down of migrant-related programs, which generated zero revenue in the first","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001822359-26-000020","anchor_url":"https://secwatch.observer/filing/0001822359-26-000020#claim-5943af32a8e9f932460a31bdd10cafa6e06ecfa7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235926000020/0001822359-26-000020-index.htm"},{"fact_type":"earnings_release","fact_key":"fc419d6802f7f51e2ecf3a648af90fe4395d7a94","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-03-16T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"Net loss for the fourth quarter of 2025 was $142.3 million","period_text":"the fourth quarter and full year ended December 31, 2025","report_date":"2026-03-16","result_type":"reported_results","revenue_text":"$74.9 million"},"claim":"DocGo Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue $74.9 million, net income Net loss for the fourth quarter of 2025 was $142.3 million. Guidance raised.","evidence_excerpt":"and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights • Total revenue for the fourth quarter of 2025 was $74.9 million, compared to $120.8 million in the fourth quarter of 2024. This decline was entirely due to the wind-down of migrant-related programs, which generated $7.4 million of revenue in","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001822359-26-000009","anchor_url":"https://secwatch.observer/filing/0001822359-26-000009#claim-fc419d6802f7f51e2ecf3a648af90fe4395d7a94","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235926000009/0001822359-26-000009-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"4d6d30f5854a664687819f7651b145c14e668318","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2026-01-30T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2026-07-27","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-01-26","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)"],"rules_cited_in_text":true},"claim":"DocGo Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"January 26, 2026, DocGo Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), from December 9, 2025 to January 23, 2026, the Company is not currently in compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market (the “Minimum Bid Requirement”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001822359-26-000003","anchor_url":"https://secwatch.observer/filing/0001822359-26-000003#claim-4d6d30f5854a664687819f7651b145c14e668318","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235926000003/0001822359-26-000003-index.htm"},{"fact_type":"executive_change","fact_key":"78be8addcc","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-09-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-10-01","interim":false,"role":"Independent Chair of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Stephen K. Klasko was appointed as Independent Chair of the Board at DocGo Inc..","evidence_excerpt":"On September 26, 2024, the Board of Directors (the “Board”) of DocGo Inc. (the “Company”) appointed Stephen K. Klasko, MD as a Class III director and independent Chair of the Board, effective as of October 1, 2024 (the “Effective Date”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000085","anchor_url":"https://secwatch.observer/filing/0001822359-24-000085#claim-78be8addcc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000085/0001822359-24-000085-index.htm"},{"fact_type":"executive_change","fact_key":"33817df150","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-09-30T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-10-01","interim":false,"role":"Chair of the Board","role_category":"chair","successor_name":"Stephen K. Klasko","successor_named":true},"claim":"Steven Katz resigned as Chair of the Board at DocGo Inc..","evidence_excerpt":"On September 25, 2024, Mr. Katz notified the Board that he intends to step down as a director and Chair of the Board, effective as of the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000085","anchor_url":"https://secwatch.observer/filing/0001822359-24-000085#claim-33817df150","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000085/0001822359-24-000085-index.htm"},{"fact_type":"earnings_release","fact_key":"d441395f97fed99721a6e9609e6f0ff5b372065c","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-05-08T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":"$10.6 million","period_text":"the quarter ended March 31, 2024","report_date":"2024-05-08","result_type":"reported_results","revenue_text":"$192.1 million"},"claim":"DocGo Inc. reported the quarter ended March 31, 2024 results: revenue $192.1 million, net income $10.6 million. Guidance lowered.","evidence_excerpt":"today announced financial and operating results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights • Total revenue for the first quarter of 2024 was $192.1 million, compared to $113.0 million in the first quarter of 2023, an increase of 70%. • Gross margin for the first quarter of 2024 was 35.0%, compared to the gross margin in the first","confidence":0.85,"filing_url":"https://secwatch.observer/filing/0001822359-24-000043","anchor_url":"https://secwatch.observer/filing/0001822359-24-000043#claim-d441395f97fed99721a6e9609e6f0ff5b372065c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000043/0001822359-24-000043-index.htm"},{"fact_type":"executive_change","fact_key":"90fa80cd36","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-03-08T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-04-01","interim":false,"role":"Chair of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Steven Katz was appointed as Chair of the Board at DocGo Inc..","evidence_excerpt":"on March 7, 2024, the Board appointed director Steven Katz to succeed Mr. Vashovsky as Chair of the Board, effective as of April 1, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000018","anchor_url":"https://secwatch.observer/filing/0001822359-24-000018#claim-90fa80cd36","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000018/0001822359-24-000018-index.htm"},{"fact_type":"executive_change","fact_key":"62f2fcd8a0","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-03-08T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-04-01","interim":false,"role":"Class I director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Lee Bienstock was appointed as Class I director at DocGo Inc..","evidence_excerpt":"On March 7, 2024, the Board of Directors (the “Board”) of DocGo Inc. (the “Company”) appointed Lee Bienstock, Chief Executive Officer of the Company, to the Board as a Class I director, effective as of April 1, 2024 following Stan Vashovsky’s departure as a director and Chair of the Board on March 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000018","anchor_url":"https://secwatch.observer/filing/0001822359-24-000018#claim-62f2fcd8a0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000018/0001822359-24-000018-index.htm"},{"fact_type":"executive_change","fact_key":"1d5f8a88e9","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-03-08T23:59:59+00:00","payload":{"action":"retired and stepped down","action_category":"departure","departure_tone":"retirement","effective_date":"2024-03-31","interim":false,"role":"Chair of the Board","role_category":"chair","successor_name":"Steven Katz","successor_named":true},"claim":"Stan Vashovsky departed as Chair of the Board at DocGo Inc..","evidence_excerpt":"on March 7, 2024, Mr. Vashovsky notified the Board that he intends to retire and step down as a director and Chair of the Board, effective as of March 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000018","anchor_url":"https://secwatch.observer/filing/0001822359-24-000018#claim-1d5f8a88e9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000018/0001822359-24-000018-index.htm"},{"fact_type":"executive_change","fact_key":"c2e56ce0de","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-03-08T23:59:59+00:00","payload":{"action":"retired and stepped down","action_category":"departure","departure_tone":"retirement","effective_date":"2024-03-31","interim":false,"role":"Director","role_category":"director","successor_name":"Lee Bienstock","successor_named":true},"claim":"Stan Vashovsky departed as Director at DocGo Inc..","evidence_excerpt":"on March 7, 2024, Mr. Vashovsky notified the Board that he intends to retire and step down as a director and Chair of the Board, effective as of March 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000018","anchor_url":"https://secwatch.observer/filing/0001822359-24-000018#claim-c2e56ce0de","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000018/0001822359-24-000018-index.htm"},{"fact_type":"earnings_release","fact_key":"d9fe6f5b776d73ca86540c4ce05ad3fc0a38e21e","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-02-28T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"Full-year 2024","report_date":"2024-02-28","result_type":"guidance_update","revenue_text":"$720-750 million"},"claim":"DocGo Inc. reported Full-year 2024 results: revenue $720-750 million. Guidance initiated.","evidence_excerpt":"Full-year 2024 revenues are expected to be $720-750 million","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001822359-24-000014","anchor_url":"https://secwatch.observer/filing/0001822359-24-000014#claim-d9fe6f5b776d73ca86540c4ce05ad3fc0a38e21e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000014/0001822359-24-000014-index.htm"},{"fact_type":"earnings_release","fact_key":"a6e595ccd6ae2a83a780cee3bdc3baefd320e0c1","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-02-28T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$10.0 million","period_text":"the year ended December 31, 2023","report_date":"2024-02-28","result_type":"reported_results","revenue_text":"$624.2 million"},"claim":"DocGo Inc. reported the year ended December 31, 2023 results: revenue $624.2 million, net income $10.0 million.","evidence_excerpt":"Full-year 2023 revenues increased to $624.2 million","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000014","anchor_url":"https://secwatch.observer/filing/0001822359-24-000014#claim-a6e595ccd6ae2a83a780cee3bdc3baefd320e0c1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000014/0001822359-24-000014-index.htm"},{"fact_type":"earnings_release","fact_key":"4bf21a1642534a48f08e61e7a408ef94e86ddb9b","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-02-28T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$8.0 million","period_text":"the quarter ended December 31, 2023","report_date":"2024-02-28","result_type":"reported_results","revenue_text":"$199.2 million"},"claim":"DocGo Inc. reported the quarter ended December 31, 2023 results: revenue $199.2 million, net income $8.0 million.","evidence_excerpt":"Total revenues for the fourth quarter of 2023 were $199.2 million","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000014","anchor_url":"https://secwatch.observer/filing/0001822359-24-000014#claim-4bf21a1642534a48f08e61e7a408ef94e86ddb9b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000014/0001822359-24-000014-index.htm"},{"fact_type":"material_agreement","fact_key":"ffadfcbd6bf8c7b55af724bc8a106d1cdc430da7","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-01-31T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amendment","agreement_type":"credit_facility","counterparty":"Citibank, N.A.","effective_date":"2024-01-30","item_codes_triggered":["1.01"],"value_text":null},"claim":"DocGo Inc. amended Amendment with Citibank, N.A. (effective 2024-01-30).","evidence_excerpt":"On January 30, 2024, DocGo Inc. (the “Company”) entered into an amendment (the “Amendment”) to the credit agreement, dated as of November 1, 2022, by and among the Company, Citibank, N.A. as administrative agent, and the other parties thereto.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001822359-24-000009","anchor_url":"https://secwatch.observer/filing/0001822359-24-000009#claim-ffadfcbd6bf8c7b55af724bc8a106d1cdc430da7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000009/0001822359-24-000009-index.htm"},{"fact_type":"earnings_release","fact_key":"197f4df07940bca07fafa01237e31f3d813b9b58","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-01-16T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"fiscal year 2023","report_date":"2024-01-16","result_type":"preliminary_results","revenue_text":null},"claim":"DocGo Inc. reported preliminary financial results for fiscal year 2023.","evidence_excerpt":"select preliminary financial results for fiscal year 2023","confidence":0.85,"filing_url":"https://secwatch.observer/filing/0001822359-24-000007","anchor_url":"https://secwatch.observer/filing/0001822359-24-000007#claim-197f4df07940bca07fafa01237e31f3d813b9b58","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000007/0001822359-24-000007-index.htm"},{"fact_type":"earnings_release","fact_key":"11f61bfdc5cf2b7c8cae1dffe88a97895f83c5d9","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-01-10T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"fiscal year 2024","report_date":"2024-01-10","result_type":"guidance_update","revenue_text":"exceed $700 million"},"claim":"DocGo Inc. reported fiscal year 2024 results: revenue exceed $700 million. Guidance initiated.","evidence_excerpt":"DocGo further expects revenue in 2024 to exceed $700 million.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000005","anchor_url":"https://secwatch.observer/filing/0001822359-24-000005#claim-11f61bfdc5cf2b7c8cae1dffe88a97895f83c5d9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000005/0001822359-24-000005-index.htm"},{"fact_type":"earnings_release","fact_key":"aa7acbd3dbb7767c86338ba1671733b0e91c290b","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2024-01-10T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"fiscal year 2023","report_date":"2024-01-10","result_type":"guidance_update","revenue_text":"between $615 million and $625 million"},"claim":"DocGo Inc. reported fiscal year 2023 results: revenue between $615 million and $625 million. Guidance reaffirmed.","evidence_excerpt":"The Company’s revenue for fiscal year 2023 is expected to be between $615 million and $625 million, in line with the Company’s previously released guidance.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-24-000005","anchor_url":"https://secwatch.observer/filing/0001822359-24-000005#claim-aa7acbd3dbb7767c86338ba1671733b0e91c290b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000005/0001822359-24-000005-index.htm"},{"fact_type":"earnings_release","fact_key":"2713f04f9fe398389b2cdd58c17f9fc5bf84b380","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-11-06T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$4.6 million","period_text":"the quarter ended September 30, 2023","report_date":"2023-11-06","result_type":"reported_results","revenue_text":"$186.6 million"},"claim":"DocGo Inc. reported the quarter ended September 30, 2023 results: revenue $186.6 million, net income $4.6 million. Guidance raised.","evidence_excerpt":"today announced financial and operating results for the quarter ended September 30, 2023. Q3 2023 Financial Highlights • Total revenue for the third quarter of 2023 was $186.6 million, up 49% from $125.5 million in the second quarter of 2023 and up 79% from $104.3 million in the third quarter of 2022. The revenue increase was driven by gains in nearly all","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-23-000031","anchor_url":"https://secwatch.observer/filing/0001822359-23-000031#claim-2713f04f9fe398389b2cdd58c17f9fc5bf84b380","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235923000031/0001822359-23-000031-index.htm"},{"fact_type":"executive_change","fact_key":"a66bd84ea8","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2023-09-15","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Anthony Capone resigned as Chief Executive Officer at DocGo Inc..","evidence_excerpt":"As previously reported, Anthony Capone resigned as the Chief Executive Officer of DocGo Inc. (the “Company”) effective September 15, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001822359-23-000020","anchor_url":"https://secwatch.observer/filing/0001822359-23-000020#claim-a66bd84ea8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000182235923000020/0001822359-23-000020-index.htm"},{"fact_type":"executive_change","fact_key":"91017d6823","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-09-15T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-09-15","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Lee Bienstock was appointed as Chief Executive Officer at DocGo Inc..","evidence_excerpt":"On September 15, 2023, the Board of Directors of the Company (the “Board”) appointed Lee Bienstock, the Company’s current President and Chief Operating Officer, as the Chief Executive Officer of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-077094","anchor_url":"https://secwatch.observer/filing/0001213900-23-077094#claim-91017d6823","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023077094/0001213900-23-077094-index.htm"},{"fact_type":"executive_change","fact_key":"5fb725d89a","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-09-15T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2023-09-15","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Lee Bienstock","successor_named":true},"claim":"Anthony Capone resigned as Chief Executive Officer at DocGo Inc..","evidence_excerpt":"Anthony Capone resigned as the Chief Executive Officer of DocGo Inc. (the “Company”) and from all other positions with the Company due to personal reasons.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-077094","anchor_url":"https://secwatch.observer/filing/0001213900-23-077094#claim-5fb725d89a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023077094/0001213900-23-077094-index.htm"},{"fact_type":"earnings_release","fact_key":"8b398de66f2f380446c4e623bcf866b37bdca03b","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-08-07T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$1.3 million","period_text":"the quarter ended June 30, 2023","report_date":"2023-08-07","result_type":"reported_results","revenue_text":"$125.5 million"},"claim":"DocGo Inc. reported the quarter ended June 30, 2023 results: revenue $125.5 million, net income $1.3 million. Guidance raised.","evidence_excerpt":"services today announced\nfinancial and operating results for the quarter ended June 30, 2023. Q2\n2023 Financial Highlights ● Total\n revenue for the second quarter of 2023 was $125.5 million, up from $113.0 million in the\n first quarter of 2023 and $109.5 million in the second quarter of 2022. Mass COVID-testing\n revenues during each of the first two quarters of 2023","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-064067","anchor_url":"https://secwatch.observer/filing/0001213900-23-064067#claim-8b398de66f2f380446c4e623bcf866b37bdca03b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023064067/0001213900-23-064067-index.htm"},{"fact_type":"shareholder_vote","fact_key":"fddbf4eb5f6542b11084720b193c7ad38dfae138","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-06-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-20","outcome":"passed","proposal_text":"Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2023","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"—","subject":null,"votes_abstain":"71,168","votes_against":"270,758","votes_for":"76,087,615","votes_withheld":null}]},"claim":"DocGo Inc. shareholders approved Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-20 meeting.","evidence_excerpt":"Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2023 (Proposal 2): Votes For Votes Against Abstention Broker Non-Votes 76,087,615 270,758 71,168 —","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-050539","anchor_url":"https://secwatch.observer/filing/0001213900-23-050539#claim-fddbf4eb5f6542b11084720b193c7ad38dfae138","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023050539/0001213900-23-050539-index.htm"},{"fact_type":"shareholder_vote","fact_key":"eed4c58701b6e4b89627f1eaeb1e397c7e6c5203","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-06-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-20","outcome":"passed","proposal_text":"Election of the two Class II director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified","proposal_type":"director_election","results":[{"broker_non_votes":"16,002,479","subject":"Vina Leite","votes_abstain":null,"votes_against":null,"votes_for":"57,368,350","votes_withheld":"3,058,712"},{"broker_non_votes":"16,002,479","subject":"James M. Travers","votes_abstain":null,"votes_against":null,"votes_for":"54,647,606","votes_withheld":"5,779,456"}]},"claim":"DocGo Inc. shareholders approved Election of the two Class II director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified at the 2023-06-20 meeting.","evidence_excerpt":"Election of the two Class II director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified (Proposal 1): Director Nominee Votes For Votes Withheld Broker Non-Votes Ms. Vina Leite 57,368,350 3,058,712 16,002,479 Mr. James M. Travers 54,647,606 5,779,456 16,002,479","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-050539","anchor_url":"https://secwatch.observer/filing/0001213900-23-050539#claim-eed4c58701b6e4b89627f1eaeb1e397c7e6c5203","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023050539/0001213900-23-050539-index.htm"},{"fact_type":"earnings_release","fact_key":"1b087dfafb3e2e4335753157ae808d2d4ec121bd","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-05-08T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"Net loss was $3.9 million","period_text":"quarter ended March 31, 2023","report_date":"2023-05-08","result_type":"reported_results","revenue_text":"$113.0 million"},"claim":"DocGo Inc. reported quarter ended March 31, 2023 results: revenue $113.0 million, net income Net loss was $3.9 million. Guidance reaffirmed.","evidence_excerpt":"today announced\nfinancial and operating results for the quarter ended March 31, 2023. Q1\n2023 Financial Highlights ● Total\n revenue, net for the first quarter of 2023 was $113.0 million, compared to $117.9 million\n in the first quarter of 2022, a decrease of 4.2%. Excluding mass COVID testing revenue from\n both periods, revenue increased 40.2% from year ago","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-037346","anchor_url":"https://secwatch.observer/filing/0001213900-23-037346#claim-1b087dfafb3e2e4335753157ae808d2d4ec121bd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023037346/0001213900-23-037346-index.htm"},{"fact_type":"earnings_release","fact_key":"c6b8744124e66dbdb97e0db70c42278f0c6deb62","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-03-13T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"Full-Year 2023","report_date":"2023-03-13","result_type":"guidance_update","revenue_text":null},"claim":"DocGo Inc. updated its Full-Year 2023 guidance (initiated).","evidence_excerpt":"Company introduces Full-Year 2023 Revenue and Adjusted EBITDA 1 Guidance of $500-$510 million and $45-$50 million, respectively","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-019594","anchor_url":"https://secwatch.observer/filing/0001213900-23-019594#claim-c6b8744124e66dbdb97e0db70c42278f0c6deb62","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm"},{"fact_type":"earnings_release","fact_key":"0799eb9df8fa504e7c431aa17ef7316571549067","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-03-13T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$7.1 million","period_text":"the fourth quarter ended December 31, 2022","report_date":"2023-03-13","result_type":"reported_results","revenue_text":"$108.8 million"},"claim":"DocGo Inc. reported the fourth quarter ended December 31, 2022 results: revenue $108.8 million, net income $7.1 million.","evidence_excerpt":"Total Q4 2022 revenue was $108.8 million, which includes approximately $1 million of COVID testing revenue, compared to $121.3 million in Q4 2021","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-019594","anchor_url":"https://secwatch.observer/filing/0001213900-23-019594#claim-0799eb9df8fa504e7c431aa17ef7316571549067","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm"},{"fact_type":"earnings_release","fact_key":"9dc1f722d1f9530254dc27da3eaf58a5180f75cc","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2023-03-13T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$30.7 million","period_text":"the year ended December 31, 2022","report_date":"2023-03-13","result_type":"reported_results","revenue_text":"$440.5 million"},"claim":"DocGo Inc. reported the year ended December 31, 2022 results: revenue $440.5 million, net income $30.7 million.","evidence_excerpt":"PRESS RELEASE OF DOCGO INC. DATED MARCH 13, 2023 ANNOUNCING EARNINGS RELEASE Exhibit\n99.1 DocGo\nAnnounces Fourth Quarter and Full-Year 2022 Results 2022\nRevenue Increased to $440.5 Million, Versus $318.7 Million in 2021, an Increase of 38% Full\nYear Revenue up 75% Year-Over-Year Excluding Mass Covid Testing Company\nintroduces Full-Year 2023 Revenue and Adjusted","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-019594","anchor_url":"https://secwatch.observer/filing/0001213900-23-019594#claim-9dc1f722d1f9530254dc27da3eaf58a5180f75cc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm"},{"fact_type":"executive_change","fact_key":"005a4205ec","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-12-29T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-01-01","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Anthony Capone was appointed as Chief Executive Officer at DocGo Inc..","evidence_excerpt":"As previously disclosed, current President Anthony Capone will assume the role of the Company’s Chief Executive Officer beginning on January 1, 2023, and Mr. Smedra will continue serving as a director on the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-083352","anchor_url":"https://secwatch.observer/filing/0001213900-22-083352#claim-005a4205ec","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022083352/0001213900-22-083352-index.htm"},{"fact_type":"executive_change","fact_key":"eb81dfdf11","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-12-29T23:59:59+00:00","payload":{"action":"retired","action_category":"role_change","departure_tone":"retirement","effective_date":"2022-12-31","interim":false,"role":"non-executive Chairman","role_category":"chair","successor_name":"Anthony Capone","successor_named":true},"claim":"Stan Vashovsky retired as non-executive Chairman at DocGo Inc..","evidence_excerpt":"On December 29, 2022 the Company announced that, while Mr. Vashovsky will retire as the Chief Executive Officer of the Company, as previously disclosed, he will continue serving as a non-executive Chairman of the Board given the strong growth outlook for the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-083352","anchor_url":"https://secwatch.observer/filing/0001213900-22-083352#claim-eb81dfdf11","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022083352/0001213900-22-083352-index.htm"},{"fact_type":"executive_change","fact_key":"1ff1fcc060","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-14T23:59:59+00:00","payload":{"action":"succeeded","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-12-31","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Norman Rosenberg was appointed as Chief Financial Officer at DocGo Inc..","evidence_excerpt":"Mr. Norman Rosenberg will succeed Mr. Oberholzer as the Chief Financial Officer of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-071594","anchor_url":"https://secwatch.observer/filing/0001213900-22-071594#claim-1ff1fcc060","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022071594/0001213900-22-071594-index.htm"},{"fact_type":"executive_change","fact_key":"f1b473308b","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-14T23:59:59+00:00","payload":{"action":"promoted","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2022-12-31","interim":false,"role":"Treasurer and Executive Vice President of Capital Markets and Strategy","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Andre Oberholzer changed role as Treasurer and Executive Vice President of Capital Markets and Strategy at DocGo Inc..","evidence_excerpt":"Mr. Andre Oberholzer will be promoted from his current role as the Company’s Chief Financial Officer to the role of Treasurer and Executive Vice President of Capital Markets and Strategy","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-071594","anchor_url":"https://secwatch.observer/filing/0001213900-22-071594#claim-f1b473308b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022071594/0001213900-22-071594-index.htm"},{"fact_type":"executive_change","fact_key":"2b7923fac6","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2022-12-31","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Lee Bienstock was appointed as President at DocGo Inc..","evidence_excerpt":"the Board appointed Mr. Lee Bienstock as the Company’s President, effective as of the Effective Time, in addition to his current role as the Company’s Chief Operating Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-071594","anchor_url":"https://secwatch.observer/filing/0001213900-22-071594#claim-2b7923fac6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022071594/0001213900-22-071594-index.htm"},{"fact_type":"executive_change","fact_key":"20d535c1d7","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-11-10","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Vina Leite was appointed as Director at DocGo Inc..","evidence_excerpt":"The Board appointed Ms. Leite to fill the newly created directorship as a Class II director","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-071594","anchor_url":"https://secwatch.observer/filing/0001213900-22-071594#claim-20d535c1d7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022071594/0001213900-22-071594-index.htm"},{"fact_type":"earnings_release","fact_key":"123bf3c87259e4030e279e58379b2d9d3ebf7090","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-07T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$2.5 million","period_text":"the third quarter ending September 30, 2022","report_date":"2022-11-07","result_type":"reported_results","revenue_text":"$104.3 million"},"claim":"DocGo Inc. reported the third quarter ending September 30, 2022 results: revenue $104.3 million, net income $2.5 million. Guidance raised.","evidence_excerpt":"2022) ---\n\nEX-99.1 2 ea168126ex99-1_docgoinc.htm PRESS RELEASE OF DOCGO INC. DATED NOVEMBER 7, 2022 Exhibit 99.1 DocGo Announces Strong Third Quarter 2022 Results Q3 Revenue of $104.3 Million Up 22% Year-Over-Year;\nCompany Raises Full-Year 2022 Revenue and Adjusted EBITDA Guidance Co-founder and CEO Stan Vashovsky announces\nhis retirement effective December 31st;","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-069776","anchor_url":"https://secwatch.observer/filing/0001213900-22-069776#claim-123bf3c87259e4030e279e58379b2d9d3ebf7090","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022069776/0001213900-22-069776-index.htm"},{"fact_type":"executive_change","fact_key":"a67c0b1d8d","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-12-31","interim":false,"role":"Chairman of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Ira Smedra was appointed as Chairman of the Board at DocGo Inc..","evidence_excerpt":"the Board also appointed Ira Smedra, an independent Class I director of the Board, to succeed Mr. Vashovsky as Chairman of the Board, effective upon the Effective Time.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-069776","anchor_url":"https://secwatch.observer/filing/0001213900-22-069776#claim-a67c0b1d8d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022069776/0001213900-22-069776-index.htm"},{"fact_type":"executive_change","fact_key":"86d7e14dd3","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2022-12-31","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Anthony Capone was appointed as Chief Executive Officer at DocGo Inc..","evidence_excerpt":"the Board appointed Anthony Capone, the Company’s current President, to succeed Mr. Vashovsky as the Chief Executive Officer of the Company, effective upon the Effective Time.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-069776","anchor_url":"https://secwatch.observer/filing/0001213900-22-069776#claim-86d7e14dd3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022069776/0001213900-22-069776-index.htm"},{"fact_type":"executive_change","fact_key":"0fbf9cfa8c","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-07T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2022-12-31","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Anthony Capone","successor_named":true},"claim":"Stan Vashovsky retired as Chief Executive Officer at DocGo Inc..","evidence_excerpt":"Stan Vashovsky notified the Board of Directors of the Company (the “Board”) that he intends to retire from the Company and step down as the Company’s Chief Executive Officer, director and Chairman of the Board, effective as of December 31, 2022","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-069776","anchor_url":"https://secwatch.observer/filing/0001213900-22-069776#claim-0fbf9cfa8c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022069776/0001213900-22-069776-index.htm"},{"fact_type":"debt_financing","fact_key":"4d25a07d229e56b9df638d04ec949cc58671e43a","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-02T23:59:59+00:00","payload":{"counterparty":"Citibank, N.A., as administrative agent","effective_date":"2022-11-01","event":"incurrence","instrument_type":"revolving_credit","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":"five-year anniversary of the Closing Date","principal_text":"$90 million"},"claim":"DocGo Inc. incurred revolving credit of $90 million with Citibank, N.A., as administrative agent maturing five-year anniversary of the Closing Date.","evidence_excerpt":"On November 1, 2022 (the “Closing Date”), DocGo Inc. (the “Corporation”) entered into a credit agreement (the “Credit Agreement”) together with each lender party thereto (collectively, the “Lenders”), and Citibank, N.A., as administrative agent (in such capacity, the “Agent”). The Credit Agreement provides for a revolving credit facility in the initial aggregate principal amount of $90 million (the “Revolving Facility”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-22-068671","anchor_url":"https://secwatch.observer/filing/0001213900-22-068671#claim-4d25a07d229e56b9df638d04ec949cc58671e43a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022068671/0001213900-22-068671-index.htm"},{"fact_type":"material_agreement","fact_key":"c59e0f173debeddefebe6d6595a214ceac593e4d","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-11-02T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Credit Agreement","agreement_type":"credit_facility","counterparty":"Citibank, N.A., as administrative agent, and the lenders party thereto","effective_date":"2022-11-01","item_codes_triggered":["1.01"],"value_text":"$90 million"},"claim":"DocGo Inc. entered into Credit Agreement with Citibank, N.A., as administrative agent, and the lenders party thereto valued at $90 million (effective 2022-11-01).","evidence_excerpt":"On November 1, 2022 (the “Closing Date”), DocGo Inc. (the “Corporation”) entered into a credit agreement (the “Credit Agreement”) together with each lender party thereto (collectively, the “Lenders”), and Citibank, N.A., as administrative agent (in such capacity, the “Agent”). The Credit Agreement provides for a revolving credit facility in the initial aggregate principal amount of $90 million (the “Revolving Facility”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-22-068671","anchor_url":"https://secwatch.observer/filing/0001213900-22-068671#claim-c59e0f173debeddefebe6d6595a214ceac593e4d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022068671/0001213900-22-068671-index.htm"},{"fact_type":"executive_change","fact_key":"286463a5af","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-04-04T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-04-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Chris Fillo resigned as Director at DocGo Inc..","evidence_excerpt":"On March 29, 2022, Chris Fillo, a member of the Board of Directors of DocGo Inc. (the “Company”), informed the Company of his decision to resign from the Board of Directors of the Company, effective April 1, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-017669","anchor_url":"https://secwatch.observer/filing/0001213900-22-017669#claim-286463a5af","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022017669/0001213900-22-017669-index.htm"},{"fact_type":"executive_change","fact_key":"6395b694e3","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-03-16T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-03-28","interim":false,"role":"Chief Operating Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Lee Bienstock was appointed as Chief Operating Officer at DocGo Inc..","evidence_excerpt":"the Board of Directors (the “Board”) of the Company approved the appointment of Lee Bienstock as the Company’s Chief Operating Officer, effective March 28, 2022.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001213900-22-012937","anchor_url":"https://secwatch.observer/filing/0001213900-22-012937#claim-6395b694e3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022012937/0001213900-22-012937-index.htm"},{"fact_type":"executive_change","fact_key":"aa49e2db89","cik":1822359,"ticker":"DCGO","company_name":"DocGo Inc.","filed_at":"2022-03-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-03-31","interim":false,"role":"Chief Operating Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Lee Bienstock was appointed as Chief Operating Officer at DocGo Inc..","evidence_excerpt":"On March 14, 2022, DocGo Inc. (the “Company”) issued a press release that announced the appointment of Lee Bienstock as the Company’s Chief Operating Officer, effective March 31, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-011996","anchor_url":"https://secwatch.observer/filing/0001213900-22-011996#claim-aa49e2db89","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390022011996/0001213900-22-011996-index.htm"}]}